Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank67
3Y CAGR-15.8%
5Y CAGR-10.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-15.8%/yr
vs +39.7%/yr prior
5Y CAGR
-10.7%/yr
Recent deceleration
Acceleration
-55.5pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $50.02M | -6.8% |
| 2025 | $53.66M | +5.9% |
| 2024 | $50.65M | -39.5% |
| 2023 | $83.70M | -47.8% |
| 2022 | $160.19M | +81.9% |
| 2021 | $88.07M | +117.6% |
| 2020 | $40.48M | +84.3% |
| 2019 | $21.96M | +12.9% |
| 2018 | $19.45M | -5.9% |
| 2017 | $20.66M | - |